Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8722
|
pubmed:dateCreated |
1990-11-20
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
336
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1067
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1977037-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:1977037-Antigens, CD4,
pubmed-meshheading:1977037-HIV Envelope Protein gp120,
pubmed-meshheading:1977037-HIV-1,
pubmed-meshheading:1977037-Humans,
pubmed-meshheading:1977037-Mycoplasma,
pubmed-meshheading:1977037-T-Lymphocytes
|
pubmed:year |
1990
|
pubmed:articleTitle |
Infection of human T cells with mycoplasma, inhibition of CD4 expression and HIV-1 gp120 glycoprotein binding, and infectivity.
|
pubmed:publicationType |
Letter
|